ABT Holding Company

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 33134
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 15240
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 9116
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 544
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
  
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 220
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0282,336 Modulation of Microglia ActivationSep 17, 15Sep 29, 16[G01N]
2016/0256,502 Modulation of Splenocytes in Cell Therapy for Traumatic Brain InjuryMar 08, 16Sep 08, 16[A61K, C12N]
2015/0093,364 USE OF STEM CELLS TO PREVENT NEURONAL DIEBACKDec 05, 14Apr 02, 15[A61K]
2014/0242,629 Modulation of AngiogenesisFeb 25, 14Aug 28, 14[C12N]
2014/0134,137 Use of Stem Cells to Reduce Leukocyte ExtravasationNov 01, 13May 15, 14[C12N]
2014/0037,596 Use of Stem Cells to Reduce Leukocyte ExtravasationOct 10, 13Feb 06, 14[A61K, G01N]
2011/0305,638 Modulation of Macrophage ActivationMar 25, 11Dec 15, 11[A61K, C12Q, C12N, A61P]
2011/0212,069 Modulation of Microglia ActivationMar 25, 11Sep 01, 11[A61K, C12Q, A61P]
2011/0177,595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived ThereofMar 07, 11Jul 21, 11[C12N]
2011/0171,659 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived ThereofOct 19, 10Jul 14, 11[C12Q]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9789136 Multipotent adult stem cells and methods for isolationJun 08, 15Oct 17, 17[A61K, C12N]
9764044 Homologous recombination in multipotent adult progenitor cellsMay 21, 10Sep 19, 17[A61K, C12N]
9617513 Pluripotent embryonic-like stem cells, compositions, methods and uses thereofJan 05, 05Apr 11, 17[A61K, C12N]
9309262 receptor ligands and uses thereofMar 07, 14Apr 12, 16[A61K, C07D]
9284277 receptor ligands and uses thereofDec 23, 13Mar 15, 16[A61K, C07D]
9096520 Tricyclic ideno-pyrrole derivatives as serotonin receptor modulatorsMar 21, 14Aug 04, 15[A61K, C07D]
8460894 Calcium-sensing receptor 2 (CaR2) and methods for usingJun 11, 09Jun 11, 13[C07H, C12P, C12N, C07K]
8153431 Compositions and methods for making mutations in cell lines and animalsJan 15, 03Apr 10, 12[C07H, C12N]
7972853 Compositions and methods for making mutations in cell lines and animalsJan 15, 03Jul 05, 11[C07H, C12N]
7842792 Compositions and methods for non-targeted activation of endogenous genesDec 30, 02Nov 30, 10[C07H, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0295,442 MODULATION OF MICROGLIA ACTIVATIONAbandonedApr 01, 14Oct 02, 14[C12Q, G01N]
2014/0206,672 THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOFAbandonedMar 19, 14Jul 24, 14[C07D]
2014/0186,307 Use of Stem Cells to Prevent Neuronal DiebackAbandonedOct 03, 13Jul 03, 14[A61K]
2012/0009,674 Use of a GSK-3 Inhibitor to Maintain Potency of Cultured CellsAbandonedJun 30, 11Jan 12, 12[C12N]
2011/0318,313 Modulation of Splenocytes in Cell Therapy for Traumatic Brain InjuryAbandonedJun 01, 11Dec 29, 11[A61K, C12N, A61P]
2011/0293,578 Use of Stem Cells to Prevent Neuronal DiebackAbandonedSep 04, 09Dec 01, 11[A61K, C12N, A61P]
2011/0217,779 Compositions and Methods for Non-Targeted Activation of Endogenous GenesAbandonedMar 01, 11Sep 08, 11[C12N]
2011/0206,647 Modulation of AngiogenesisAbandonedMar 25, 11Aug 25, 11[A61K, C12Q, C12N, A61P]
2011/0020,293 Use of Stem Cells to Reduce Leukocyte ExtravasationAbandonedJul 21, 10Jan 27, 11[A61K, C12Q, C12N, A61P, C40B]
2010/0311,612 Compositions and Methods for Making Mutations in Cell Lines and AnimalsAbandonedJan 13, 10Dec 09, 10[C12Q, C12N, C40B]
2010/0010,196 COMPOSITIONS AND METHODS FOR NON-TARGETED ACTIVATION OF ENDOGENOUS GENESAbandonedJun 26, 09Jan 14, 10[C07H, C12P, C12N, C07K]
2008/0194,021 Use of a Gsk-3 Inhibitor to Maintain Potency of Culture CellsAbandonedJul 31, 06Aug 14, 08[C12N]
2008/0194,024 Culture of Non-Embryonic Cells at High Cell DensityAbandonedJul 31, 06Aug 14, 08[C12N]
2008/0064,764 Calcium-sensing receptor 2 (CAR2) and methods for usingAbandonedApr 10, 07Mar 13, 08[A61K, C07H, C12Q, C12P, C12N, G01N, A61P, C07K]
2006/0228,798 Homologous recombination in multipotent adult progenitor cellsAbandonedNov 25, 03Oct 12, 06[C12N]
2004/0253,589 COMPOSITIONS AND METHODS FOR MAKING MUTATIONS IN CELL LINES AND ANIMALSAbandonedJan 15, 03Dec 16, 04[C12Q, C12N]
2004/0253,590 COMPOSITIONS AND METHODS FOR MAKING MUTATIONS IN CELL LINES AND ANIMALSAbandonedJan 15, 03Dec 16, 04[C12Q, C12N]
2004/0033,214 Pluripotent embryonic-like stem cells, compositions, methods and uses thereofAbandonedMay 22, 03Feb 19, 04[C12N]
2004/0018,624 Compositions and methods for making mutations in cell lines and animalsAbandonedOct 22, 02Jan 29, 04[C12N]
2003/0161,817 Pluripotent embryonic-like stem cells, compositions, methods and uses thereofAbandonedMar 28, 01Aug 28, 03[A61K, C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.